CTOs on the Move

Authentium

www.authentium.com

 
Authentium, Inc. is a Palm Beach Gardens, FL-based company in the Software and Internet sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.authentium.com
  • 7121 Fairway Dr Ste 102
    Palm Beach Gardens, FL USA 33418
  • Phone: 561.575.3200

Executives

Name Title Contact Details

Similar Companies

Serus

Serus is a Sunnyvale, CA-based company in the Software and Internet sector.

ROK Technologies

ROK Technologies, LLC, based in Charleston, South Carolina, serves clients in many industries and governments globally. As an Esri Silver business partner and ArcGIS® Server Application Service Provider licensee, they are able to leverage the entire ArcGIS® platform, including ArcGIS® for server hosting, application development, and virtualized desktop software - available from anywhere, on any device. ROK`s cutting edge core competencies and secure private cloud infrastructure provide their clients the tools they need integrate their enterprise software with GIS solutions, products and services.

ScreenScape Networks

ScreenScape is an online service for engaging audiences in real world places through the use of digital displays.

CaseNET

CaseNET is a Bedford, MA-based company in the Software and Internet sector.

Cypher Genomics

Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.